Emergency Use Authorization

FDA Authorizes Novavax COVID-19 Vaccines for Circulating Variants

October 4, 2023 - Yesterday, on October 3, 2023, the United States Food and Drug Administration (FDA) announced an emergency use authorization (EUA) for an updated Novavax COVID-19 vaccine to protect against the currently circulating SARS-CoV-2 variants. According to the release, the newest Novavax vaccine includes components targeting the XBB.1.5 omicron variant...

Read More


More Articles

Neutralizing Monoclonal Antibodies for COVID-19 Reduces ED Visits

by Veronica Salib

On April 24, 2023, researchers published the results of a cohort study analyzing the effect of neutralizing monoclonal antibodies (nMABs) on patients with COVID-19, noting significantly improved...

FDA Updates EUA for Bivalent mRNA COVID-19 Vaccines to Simplify Use

by Veronica Salib

On April 18, 2023, the FDA issued an announcement, updating the emergency use authorization (EUA) for the bivalent mRNA COVID-19 vaccines. Attempting to simplify use for healthcare professionals, the...

FDA Approves Bivalent COVID Boosters

by Veronica Salib

As the COVID pandemic progresses and new variants appear, clinicians and public health professionals have been concerned about the level of vaccine protection for new variants and subvariants. To...

FDA Expands Emergency Use Authorization for Novavax COVID Vaccine in Kids

by Veronica Salib

As the COVID pandemic progresses and infection rates fluctuate, public health officials and organizations seek to provide more options to protect against illness. On August 19, Novavax announced that...

FDA Advisory Board Unanimously Votes to Approve Pfizer COVID Vaccine for Kids under 5

by Veronica Salib

On June 15, the FDA advisory board unilaterally voted to approve Pfizer’s COVID vaccine for children under 5. Until now, there has been a gap in COVID-related care for children under 5 as...

FDA Gives EUA for Genentech’s Actemra for COVID-19 Hospitalizations

by Kyle Murphy, PhD

Genentech’s COVID-19 drug therapy Actemra (tocilizumab) is the latest to receive an emergency use authorization, FDA announced Thursday. The EUA makes the drug available to treat hospitalized...

Emergency Use Authorization Granted for GSK-Vir COVID-19 Antibody

by Samantha McGrail

FDA recently issued an emergency use authorization (EUA) for GSK and Vir Biotechnology’s COVID-19 antibody therapy, sotrovimab. The therapy is intended to treat mild-to-moderate coronavirus in...

FDA Rescinds EUA for Eli Lilly’s Monoclonal COVID-19 Antibody

by Samantha McGrail

FDA recently revoked the emergency use authorization that allowed for Eli Lilly & Company’s monoclonal COVID-19 antibody, bamlanivimab, to be used for coronavirus treatment in adults and...

Eli Lilly Asks FDA to Revoke the EUA for COVID-19 Antibody Drug

by Samantha McGrail

Eli Lilly and Company recently requested that FDA revoke the emergency use authorization for its COVID-19 antibody treatment. The FDA’s authorization has allowed providers to use 700 milligrams...

FDA Issues EUA for Abbott’s At-Home COVID-19 Antigen Test

by Samantha McGrail

FDA recently issued an emergency use authorization (EUA) for Abbott’s COVID-19 antigen test, the BinaxNOW COVID-19 Ag Card Home Test, for use by patients with a prescription.  The test is...

FDA Issues Second COVID-19 Vaccine EUA to Moderna for mRNA Shot

by Hannah Nelson

The Food and Drug Administration has issued the second emergency use authorization (EUA) for a COVID-19 vaccine to Moderna, allowing for national distribution. All available data show that the vaccine...

FDA Issues EUA For Pfizer-BioNTech COVID-19 Vaccine

by Hannah Nelson

The US Food and Drug Administration (FDA) has issued the first emergency use authorization (EUA) for a COVID-19 vaccine to Pfizer-BioNTech, allowing for distribution across the country. The totality...

FDA Says It Will Approve EUA for Pfizer’s COVID-19 Vaccine

by Samantha McGrail

Following a positive advisory committee meeting outcome regarding the Pfizer-BioNTech COVID-19 vaccine, FDA stated that it will rapidly work toward finalization and issuance of an emergency use...

FDA Grants Emergency Use Authorization to Yale for COVID-19 Test

by Samantha McGrail

FDA recently issued an emergency use authorization (EUA) to Yale School of Public Health for its SalivaDirect COVID-19 test. For more coronavirus updates, visit our resource page, updated twice...

Emergency Use Authorization Issued for COVID-19 Pooled Testing

by Samantha McGrail

FDA recently reissued an Emergency Use Authorization (EUA) to Quest Diagnostics for its sample COVID-19 pooled testing tool. For more coronavirus updates, visit our resource page, updated twice...

FDA Grants EUA for Becton Dickinson’s Rapid COVID-19 Antigen Test

by Samantha McGrail

FDA recently issued an Emergency Use Authorization (EUA) for a rapid COVID-19 antigen diagnostic test that can be used at the point of care. For more coronavirus updates, visit our resource page,...

FDA Rescinds Emergency Use Authorization for COVID-19 Antibody Test

by Samantha McGrail

FDA recently revoked the emergency use authorization (EUA) for the SARS-CoV-2 antibody test, Chembio Diagnostic System (Chembio), due to performance concerns, according to an official press...

FDA Reverses Emergency Use Authorization for Hydroxychloroquine

by Samantha McGrail

FDA recently revoked the Emergency Use Authorization (EUA) for chloroquine phosphate (CQ) and hydroxychloroquine sulfate (HCQ), according to an official announcement. For more coronavirus updates,...

FDA Grants Emergency Use Authorization for COVID-19 Serology Test

by Samantha McGrail

FDA recently issued an Emergency Use Authorization (EUA) for Abbott’s SARS-CoV-2 IgG lab-based serology blood test on the Alinity i system.  For more coronavirus updates, visit...

Recent Articles